West Virginia Attorney General J.B. McCuskey announced Monday that the state is following the lead of several other states in ...

As Express Scripts’ chief medical officer, Dr. Steve Miller plays a key role in the pharmaceutical scene. He’s working to combat high drug prices, helping consumers get the drugs they need, and ...

Express Scripts doesn't have to worry about losing its second-largest customer, the U.S. Department of Defense, anytime soon. The DOD extended its contract in 2014 for another seven years.

And again, Express Scripts noted in their letter that they will no longer be doing service with Martella’s, beginning August 15th. EXPLAINER | What is a PBM and how do they impact local pharmacies?

Express Scripts is not making electric cars or shifting the social paradigm; it's a healthcare company, and before you get your hopes up... no, it's not a biotech co. developing a cure for cancer ...

Express Scripts move is bad news for these companies. In the last few years, the biotechnology industry has faced issues such as patent expirations and healthcare reform.

Customers of Cigna and Express Scripts probably won’t see an immediate benefit in the way of lowered premiums or cheaper drugs once the $52-billion merger between two of the largest healthcare ...

Express Scripts doesn't have to worry about losing its second-largest customer, the U.S. Department of Defense, anytime soon. The DOD extended its contract in 2014 for another seven years.

Express Scripts doesn't have to worry about losing its second-largest customer, the U.S. Department of Defense, anytime soon. The DOD extended its contract in 2014 for another seven years.

The company expects adjusted earnings growth for full-year 2016 of 15% to 16%. 4. Selling season is going well Express Scripts said that the selling season for 2017 is going very well.

This article is more than 8 years old. I have been writing a lot about Pharmacy Benefits Manager (PBM) giant Express Scripts (ESRX) lately, and decided to update my valuation of the company.